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Opiate Addiction and Considerations for Anesthesia
Robert Saltanovitz RN, BSN, CCRN
Otterbein University, Westerville, Ohio
Opioid Statistics in
the United States

According to the Center for Disease
and Prevention from 1999 to 2017
around 218,000 Americans have died
from prescription opioid overdoses.
Deaths from opioid prescription related
overdoses were five times greater in 2017
then in 1999. Prescription opioids are
prescribed for moderate-to-severe pain,
after surgery or injury, or for health
conditions such as cancer.
Due to the high risk for addiction,
there has been a push by the government
to promote awareness and promote
stricter guidelines for prescription and
alternative options to treat pain.
From 2006 to 2017 There has been a
19% reduction opioid prescriptions.
Despite this reduction, in 2017 there has
been almost 58 opioid prescriptions
written for every 100 Americans. The
average number days per prescription
continues to increase at about 18 days per
prescription.
Forty-six people die every day from
opioid prescriptions. Prescriptions
account for 35% of all opioid overdose
deaths. Most common drugs involved in
overdose deaths include:
•
Methadone
•
Oxycodone
•
Hydrocodone
Of those who died from opioid deaths:
•
Overdose was more likely for those
over 65 years of age.
•
Rates were higher among nonHispanic and American Indians
•
Per 100,000 people men died at a
rate of 6.1 and women 4.2 ("Centers
for Disease Control and Prevention,"
2018).

Pathophyiology of
Addiction

The mesocortical dopamine system is a
prominent system in the brain’s reward
pathway. This pathway is activated in
opioid users through activation of
dopamine receptors that causes the “high”
sensation.
In the Ventral tegmental area,
dopaminergic neurons innervate the
nucleus accumbens. Opioids inhibit
GABAergic interneurons located in the
ventral tegmental area, this leads to
activation of dopamine neurons and
increase dopamine in the nucleus
accumbens. The role of the nucleus
accumbens is to translate motivational
signals from the limbic system into goaloriented behavior and self-control (SadatShirazi et al., 2018)

Pathophysiology of Addiction

The amygdala attributes emotional value to cues. This
complex brain structure also plays a critical role in mood
regulation and stress reactivity during withdrawal. Studies
have demonstrated that the volume of the amygdala is reduced
in opiate abusers which can lead to abnormalities in the
cognitive memory task and decision making. In opiate users
have reward tolerance due to an upregulation of dopamine
receptors in the amygdala. There is increased dopaminergic
neuron activity, yet release of dopamine is reduced. This leads
to a hypersensitivity to pain as well as increased likelihood for
patients to be pleasure seeking, that is extenuated during
times of stress Sadat-Shirazi et al., 2018)

Signs and Symptoms of
Opioid Addiction Opioid abuse
Opioid withdrawal
•
Dysphoric mood
•
Nausea or vomiting
•
Lacrimation
•
Rhinorrhea
•
Muscle aches
•
Pupillary dilation
•
Piloerection
•
Sweating
•
Diarrhea
•
Yawning
•
Fever
•
Insomnia

•
•
•
•
•
•
•
•
•
•

Vomiting
Pruritus
Sweating
Twitching
Miosis
Loss of appetite
Drowsiness
Respiratory
Depression
Coma
Needle marks
(Coluzzi et al., 2017)

Evaluation for Preoperative Patients

Nurses and nurse anesthetists will encounter patients with known and
unknown opioid use. It is essential to properly evaluate patients so that
the proper measures can be taken to properly treat their pain before,
during, and post operatively while reducing the risk for surgical morbidity
and mortality. Key points to consider:
1.
Always consider the question: “Is my patient an opioid user or
abuser?”
2.
Always obtain details for the type of opiate, the duration of use,
dose, and timing of last dose.
3.
Recognize symptoms of opioid abuse and withdrawal as quickly as
possible.
4.
Identify population at risk.
5.
Obtain complete history, including physical and diagnostic studies
6.
Assess for common comorbidities in addicted patients.
7.
Consider coexisting psychiatric disorders.
8.
Avoid prejudices and assure the patient.
9.
Keep in mind fears the patient has
10.
Develop a plan for perioperative pain medication(Coluzzi et al.,
2017).

Common Myths to Avoid
1.
2.
3.
4.

Buprenorphine or methadone provides analgesia.
Opioids for analgesic will cause relapse for patients at risk for
addiction.
Patients that require additional opioids for analgesia may cause
respiratory depression and central nervous system depression.
Patient-Controlled Analgesia is inadequate for opioid tolerant
patients post-operatively (Coluzzi et at., 2017).

Gray matter volume increase in the hypothalamus following one month of daily morphine exposure. (a) Sagittal
view (x = +1) of volume increase in the caudal aspect of the hypothalamus (average volume increase = 3.1%).
(b) Same hypothalamus cluster presented in coronal plane and (c) in sagittal plane. (d) Bar graph showing
percent volumetric change from baseline in the hypothalamus for the placebo group (left bar) and morphine
group (right bars). Dark gray bars indicate the post-medication period, and light gray indicates the follow-up
period. Hypothalamus volume is significantly increased after morphine exposure, and the increased volume is
maintained 4.7 months later at the follow-up period. The placebo group shows no significant change in
hypothalamus volume. (e) Post-hoc scatterplot showing relationship between total morphine consumed (x axis)
and percent change of hypothalamic volume (y axis) in the morphine group. (Younger et al., 2012)

Gray matter volume decrease in the amygdala following one month of daily morphine
Exposure. Bar graph showing percent volumetric change from baseline in the amygdala for the
placebo group (left bar) and morphine group (right bars). Dark gray bars indicate the post medication
period, and light gray indicates the follow-up period. Amygdala volume is significantly decreased after
morphine exposure,
and the decreased volume is maintained 4.7 months later at the follow-up period. The
placebo group shows no change in amygdala volume. (c) Post-hoc scatterplot showing
relationship between total morphine consumed (x axis) and percent change in right
amygdala volume (y axis) in the morphine group. One outlier showed no amygdala change
over time.
(Younger et al., 2012)

Multimodal Options for Anesthesia Providers

Anesthesia providers can utilize a variety of nonopioid medications to reduce the overall use of opiates required
for patients with an opioid tolerance before, during, and post-operatively.
•
Acetaminophen
•
Metabolite of medication works on brain and spinal cord to help reduce amounts of opioids
required for pain reduction.
•
Nonsteroidal anti-inflammatory drugs
•
Reduces prostaglandin release which reduces inflammation and thus pain.
•
Ketamine
•
Studies show this medication works on N-methyl-D-aspartate receptor involved in the pain
pathway. Patients required fewer opioids during surgery while on ketamine.
•
Gabapentin and pregabalin
•
Medication agonise alpha2 receptors, thus decreasing pain signal transmission.
•
Local Anesthetics
•
Work by blocking sodium channels of nerve fibers, there-by inhibiting the conduction of
sensory and motor nerve impulses. These can be further classified into regional nerve blocks,
spinals, epidurals, and infiltration. These are very promising in reducing overall opioid
requirements. The FDA recently granted permission of liposomal local anesthetics that allow
for slow release pain relief to decrease opioid use post-operatively.
•
Transcutaneous electrical nerve stimulation
•
Being used more frequently. Involves electrical stimulation to sensory nerves that activate
inhibiting centers of the central nervous system.
•
Nonpharmacological interventions
•
Education, Rest, ice,
compression,
It is important for anesthesia providers to remain empathetic and see the
elevation. Cooling
situation of addiction from the patient’s point of view. Often times the patients
and heating
are from a lower social economic background and have many co-morbidities.
(Johnson & Patel,
Often providers will experience a disjunct with a patient’s expectations for
2019)
pain management and the reality of what is available for their pain
management. The current climate places many restrictions on opioid
prescriptions, this can make it difficult when determining the best options to
adequately care for a patient’s needs. Current research shows that there
burnout caring for patients when addicted to opioids, because providers want
to care for the patient, but are not properly trained to utilize other options to
treat patients with chronic pain. The prevalence of poverty among chronic
pain patients requires that providers see their job differently. More advocacy
for improving patients access to resources and provide for patients basic needs
is an important step in adjunct with reducing opiate usage. There are many
socio-economic components that many patients with chronic pain cannot
access that many providers do not realize due to their privilege in socioeconomic status. Physiotherapy, massage, exercise, and mental health access
may be great alternatives for patients with chronic pain that a provider can
utilize or advocate for. It is important as providers to lobby and vote for out
patients to have access to these alternative therapies to reduce opioid use and
abuse (Webster et al., 2019).

Considerations or Providers
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